On this episode of Molecular Moments, BioAgilytix Chief Scientific Officer Jim McNally chats with the company’s President & CEO about the exciting new updates that are putting BioAgilytix at the forefront of biotech on a global level. From multiple acquisitions to a new investor that sees the bigger picture, Datin shares how these opportunities came to be and what major deciding factors came into play when finalizing the acquisitions. The two biotech companies acquired, MicroConstants in San Diego, California, and 360biolabs in Melbourne and Brisbane Australia, are leaders in bioanalysis, and both are aligned with the BioAgilytix core values: Integrity, Customer Experience, Accountability, Respect, and Employee Experience.
They also discuss BioAgilytix’s new London-based investor Cinven, which will create the opportunity to grow BioAgiliytix through additional acquisitions, building additional campuses, ensuring state-of-the-art equipment at all locations, and the opportunity for professional development.
See omnystudio.com/listener for privacy information.
Dateline NBC
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations.
Death, Sex & Money
Anna Sale explores the big questions and hard choices that are often left out of polite conversation.
Stuff You Should Know
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.